PRESS RELEASE published on 09/17/2025 at 14:00, 1 year 1 month ago Informations privilégiées / Autres communiqués Teva et Medincell présenteront les résultats de phase 3 de l'Olanzapine LAI à Psych Congress 2025, préparant le lancement du traitement de la schizophrénie avec Teva Schizophrénie Phase 3 Medincell Teva Olanzapine LAI
BRIEF published on 09/12/2025 at 07:35, 1 year 1 month ago Medincell Appoints Three New Board Members Innovation Biopharmaceutical Leadership Board Appointments Medincell
BRIEF published on 09/12/2025 at 07:35, 1 year 1 month ago Medincell nomme trois nouveaux membres au conseil d'administration Innovation Biopharmaceutique Direction Nominations Au Conseil D'administration Medincell
PRESS RELEASE published on 09/12/2025 at 07:30, 1 year 1 month ago Inside Information / Other news releases Medincell appoints Dr. Sharon Mates, Dr. Charles Kunsch, and Dr. Pascal Touchon to its Board of Directors, adding valuable expertise in biotech and pharmaceutical sectors Board Of Directors Medincell Dr. Sharon Mates Dr. Charles Kunsch Dr. Pascal Touchon
PRESS RELEASE published on 09/12/2025 at 07:30, 1 year 1 month ago Informations privilégiées / Autres communiqués Medincell nomme le Dr Sharon Mates, le Dr Charles Kunsch et le Dr Pascal Touchon au conseil d'administration lors de l'AG annuelle et extraordinaire. Contribution cruciale pour l'avenir de l'entreprise Conseil D'administration Medincell Dr Sharon Mates Dr Charles Kunsch Dr Pascal Touchon
BRIEF published on 09/10/2025 at 21:46, 1 year 1 month ago UZEDY® obtient l'approbation en Corée du Sud après son succès aux États-Unis Schizophrénie UZEDY Approvisionnement Médical Teva Handok Marché Coréen
BRIEF published on 09/10/2025 at 21:46, 1 year 1 month ago UZEDY® Obtains Approval in South Korea Following Success in the United States Schizophrenia UZEDY Teva Handok Medical Supply Korean Market
PRESS RELEASE published on 09/10/2025 at 21:41, 1 year 1 month ago Informations privilégiées / Autres communiqués UZEDY(R) approuvé en Corée du Sud après un lancement réussi aux États-Unis. Medincell percevra des royalties sur les ventes et est éligible à des milestones commerciaux Schizophrénie Approbation Medincell Corée Du Sud UZEDY
PRESS RELEASE published on 09/10/2025 at 21:41, 1 year 1 month ago Inside Information / Other news releases Teva Handok announces regulatory approval for UZEDY® in South Korea by Ministry of Food and Drug Safety, following successful US launch. Medincell's long-acting injectable for schizophrenia shows strong commercial performance Regulatory Approval Schizophrenia Medincell Commercial Performance Teva Handok
BRIEF published on 08/04/2025 at 14:05, 1 year 2 months ago Medincell Annonce son Assemblée Générale 2025 Gouvernance Assemblée Générale Resolutions Medincell Rémunérations
Published on 10/30/2026 at 23:35, 5 hours 4 minutes ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 5 hours 9 minutes ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 7 hours 52 minutes ago CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 9 hours 39 minutes ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 13 hours 9 minutes ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/30/2026 at 22:49, 5 hours 50 minutes ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 10 hours 1 minute ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 5 hours 39 minutes ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 5 hours 39 minutes ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
